Pascal Senn
Pascal Senn is an expert in Otolaryngology at University Hospital of Geneva (Switzerland). As of October 2026, ScienceLeadR ranks Pascal Senn in the top 1% of experts worldwide for Hearing Disorders. Pascal Senn has authored 142 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 1 of them ongoing. SLR score: 432 (community average: 125). How the SLR is computed.
LeadR Profile
Otolaryngology
Subspecialties: Radiotherapy - Medical Imaging - Neurology
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 1998 - 2026
Number : 142
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| « Volume et résultats » en chirurgie des cancers de la tête et du cou. PMID 42817527 — neoplasms | Rev Med Suisse | 2026 | 0 |
| NADPH oxidase 3 inhibition preserves hearing in mice after stereotactic radiosurgery. PMID 42621021 — cochlea, radiosurgery, stress, physiological, nadp, hearing, oxidative stress, therapeutics, hearing loss, neuroma, acoustic, nadph oxidases | Mol Ther Nucleic Acids | 2026 | 0 |
| From thunder to silence: Cochlear implantation for bilateral profound sensorineural hearing loss after lightning strike. PMID 42562901 — fistula, hearing, strikes, employee, hearing loss, sensorineural, lightning, hearing loss, cochlear implantation, wounds and injuries, membranes, perilymphatic fistula | Eur Arch Otorhinolaryngol | 2026 | 0 |
| Introducing a translationally relevant mouse model of radiosurgery-induced unilateral hearing loss. PMID 42182064 — cochlea, radiosurgery, ear, hearing, hearing loss, unilateral, hearing loss, neuroma, acoustic | Front Neurosci | 2026 | 0 |
| [Innovation in the radiotherapy management of vestibular schwannomas]. PMID 42145123 — radiotherapy, radiosurgery, therapeutics, neuroma, acoustic, neurilemmoma | Rev Med Suisse | 2026 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Radiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma NCT05641441 — quality of life, ototoxicity, radiosurgery, acoustics, neuroma, hearing, hearing loss, neuroma, acoustic, neurilemmoma | N/A | Recruiting | 2023 |
LeadR Networks
Main global connection map